For the Inventor, By the Inventor

Enter assignee name

Planegg, Germany

Ethris Gmbh

USPTO Granted Patents = 28

% Expired Patents = 3.6

CIPO Patents = 2

EPO Patents = 21

Forward Citations = 132

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Carsten Rudolph (26 out of 27 patents)

Christian Plank (14 out of 15 patents)

Manish Kumar Aneja (7 out of 7 patents)

4. Braydon Charles Guild (7 out of 61 patents)

5. Michael W Heartlein (7 out of 187 patents)

6. Johannes Geiger (6 out of 6 patents)

7. Ludwig Weiss (5 out of 6 patents)

8. Frank DeRosa (5 out of 146 patents)

9. Lianne Smith (4 out of 13 patents)

10. Christian Dohmen (4 out of 4 patents)

11. Johannes-Peter Geiger (4 out of 4 patents)

12. Mehrije Ferizi (2 out of 2 patents)

13. Rebekka Kubisch-Dohmen (2 out of 2 patents)

14. Günther Hasenpusch (2 out of 2 patents)

15. Frank Derosa (2 out of 25 patents)

28 patents: Sort by Forward Citations

1. 12728151 - TREATMENT OF CILIOPATHIES (2026-09-08),

2. 12697301 - Pulmonary Delivery of MRNA to Non-lung Target Cells (2026-08-04),

3. 12594295 - CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES (2026-04-07),

4. 12522821 - Polyribonucleotide containing deuterated nucleotides (2026-01-13),

5. 12509679 - MRNA PURIFICATION BY TANGENTIAL FLOW FILTRATION (2025-12-30),

6. 12465568 - Cryoprotective agents for particulate formulations (2025-11-11),

7. 12263229 - Induction of osteogenesis by delivering BMP encoding RNA (2025-04-01),

8. 12064484 - Compositions for introducing RNA into cells (2024-08-20),

9. 11981910 - Minimal UTR sequences (2024-05-14),

10. 11510937 - CFTR MRNA compositions and related methods and uses (2022-11-29),

11. 11479768 - ATP-binding cassette family coding polyribonucleotides and formulations thereof (2022-10-25),

12. 11352638 - Minimal UTR sequences (2022-06-07),

13. 11136585 - UTRs increasing the translation efficiency of RNA molecules (2021-10-05),

14. 11104887 - Ornithine transcarbamylase coding polyribonucleotides and formulations thereof (2021-08-31),

15. 11090264 - Pulmonary delivery of mRNA to non-lung target cells (2021-08-17),

Ethris GmbH is a biotechnology company focused on the discovery, development, and commercialization of RNA-based therapeutics. Applying their proprietary messenger RNA platform, they aim to tackle diseases with high unmet medical need, including rare genetic disorders and respiratory diseases. With their expertise in RNA engineering, delivery systems, and manufacturing processes, Ethris is dedicated to providing innovative treatments that can improve the lives of patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

28 Patents

#4 in Planegg

#1,694 in Germany

#23,215 in the World

Planegg, Germany

Ethris Gmbh

Forward Citations = 132

24 inventors:

Carsten Rudolph (26 out of 27 patents)

Christian Plank (14 out of 15 patents)

Manish Kumar Aneja (7 out of 7 patents)

4. Braydon Charles Guild (7 out of 61 patents)

5. Michael W Heartlein (7 out of 187 patents)

Please report any incorrect information to [email protected]

Loading…